OpenClaw Creator Peter Steinberger: AI Innovator Rising
After a long hiatus from the tech scene, Peter Steinberger—a millennial coder turned OpenClaw founder—re-emerged to w...
When To Choose Index Funds Over Bonds
Index funds and bonds serve different roles in a diversified portfolio. This guide explains when index funds may be preferred over bonds and how to balance exposure.
25,248 articles
Bitcoin, Ether Hold Strong After Global 10% Tariff Shock
Bitcoin and Ether defy a tariff shock, keeping prices steady as markets assess broader implications for crypto liquid...
Realty Income Earnings Preview: Wall Street Watches AFFO
Realty Income is set to report Q4 2025 results after the close, with investors focused on whether the company maintai...
Sempra (SRE) 2025 Earnings: Q4 Call Highlights for Investors
As Sempra wraps up the 2025 fiscal year, investors want clarity on the Q4 2025 earnings trajectory. This article brea...
Exclusive: CrowdStrike SentinelOne Veterans Lead AI Governance Push
JetStream Security, founded by veterans of CrowdStrike and SentinelOne, closes a $34 million seed round to bring real...
Bitcoin Reaches $74K, Risk of $70K Break
Bitcoin surged to an intraday high near $74,000 on a choppy trading day, but traders warn that a sustained drop below...
XRP Price Prediction: ChatGPT DeepSeek See 2026 Upside
Two AI-powered forecasts tilt in favor of XRP versus Bitcoin through 2026. ChatGPT and DeepSeek paint a scenario wher...
Bitcoin’s Next Move Increasingly Linked to Oil and Yields
As ETF flows shift risk appetite, bitcoin’s next move increasingly depends on macro signals from oil prices, yields, ...
Bridgeport Shooting Probe Flags Ambulance Delays in City Response
A newly released inspector general report into a Bridgeport shooting finds the pursuit justified but highlights ambul...
QuantumScape Stock Down 63%: Is It Time to Buy for the Long Haul?
QuantumScape faces a volatile path from lab breakthroughs to mass production. This guide breaks down what the stock d...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Fortune Brands Never Officially Reaches Leadership Shakeup
Fortune Brands Innovations stunned investors with a leadership overhaul after a zero-day CEO exit yielded $18.4 milli...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status